The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.

Clinical and Experimental Immunology
G HalpertH Amital

Abstract

Despite undeniable improvement in the management of rheumatoid arthritis (RA), the discovery of more effective, less toxic and, ideally, less immune suppressive drugs are much needed. In the current study, we set to explore the potential anti-rheumatic activity of the non-toxic, tellurium-based immunomodulator, AS101 in an experimental animal model of RA. The effect of AS101 was assessed on adjuvant-induced arthritis (AIA) rats. Clinical signs of arthritis were assessed. Histopathological examination was used to assess inflammation, synovial changes and tissue lesions. Very late antigen-4 (VLA-4)+ cellular infiltration was detected using immunohistochemical staining. Enzyme-linked immunosorbent assay (ELISA) was used to measure circulating anti-cyclic citrullinated-peptide autoantibody (ACPA) and real-time polymerase chain reaction (PCR) was used to measure the in-vitro effect of AS101 on interleukin (IL)-6 and IL-1β expression in activated primary human fibroblasts. Prophylactic treatment with intraperitoneal AS101 reduced clinical arthritis scores in AIA rats (P < 0·01). AS101 abrogated the migration of active chronic inflammatory immune cells, particularly VLA-4+ cells, into joint cartilage and synovium, reduced the extent o...Continue Reading

References

Aug 1, 1991·The Journal of Clinical Investigation·A LaffónF Sánchez-Madrid
Jan 3, 1996·International Journal of Cancer. Journal International Du Cancer·B SredniY Kalechman
Feb 22, 2002·Medicinal Research Reviews·Helena Yusuf-MakagiansarTeruna J Siahaan
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yona KalechmanBenjamin Sredni
Apr 5, 2005·Autoimmunity·Christian VincentGuy Serre
Jun 19, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Miri BrodskyBenjamin Sredni
Feb 26, 2011·Clinical Rheumatology·Ferdinand Breedveld
Jun 8, 2011·Nature Reviews. Rheumatology·Walther J van VenrooijGer J M Pruijn
Nov 15, 2011·Arthritis Research & Therapy·Torsten Lowin, Rainer H Straub
Dec 14, 2011·The New England Journal of Medicine·Iain B McInnes, Georg Schett
Dec 29, 2011·Seminars in Cancer Biology·Benjamin Sredni
Aug 8, 2014·Arthritis Research & Therapy·Stéphanie PutPatrick Matthys
Aug 26, 2014·Autoimmunity Reviews·Gilad Halpert, Benjamin Sredni
Dec 1, 2015·Clinical and Experimental Immunology·T BashiY Shoenfeld
Aug 27, 2017·The Journal of Investigative Dermatology·Rhiannon M Kelsh-LasherPaula J McKeown-Longo
Dec 6, 2017·Calcified Tissue International·Jae-Hyuck ShimEllen M Gravallese
Jan 19, 2019·Advances in Rheumatology·Sara de Brito RochaLuis Eduardo Coelho Andrade
Mar 20, 2019·International Journal of Molecular Sciences·Shyi-Jou ChenHuey-Kang Sytwu
Apr 21, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Arwa MorshedHanmei Xu
May 13, 2020·Nature Reviews. Rheumatology·Gyrid Nygaard, Gary S Firestein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here